Skip to main content
Premium Trial:

Request an Annual Quote

PerkinElmer to Distribute Axxam's GPCR Screening Platform; Firms to Create Joint R&D Program

NEW YORK (GenomeWeb News) — PerkinElmer said today it will distribute to drug companies worldwide a luminescent cell-based assay made by Italian company Axxam.
 
The companies also agreed to create a joint R&D program to develop Photina GPCR and ion-channel lines to profile compounds and in high-throughput screening studies.
 
PerkinElmer said terms of the deal call for it to distribute the Photina photoprotein system, which is used to screen drug-discovery targets such as G-protein coupled receptors and ion channels.
 
The deal allows Axxam to continue to use Photina in its own drug-development service to third-party clients, the company said.
 
PerkinElmer said the agreement with Axxam enhances the capabilities it gained through its December acquisition of Euroscreen products and its own AequoScreen cellular assay platform.

The Scan

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.

Tibetan Study Finds Adaptive Variant Influencing Skin Pigmentation

With a combination of phenotyping and genetic data, researchers document at PNAS a Tibetan-enriched enhancer variant influencing melanin synthesis and ultraviolet light response.

Domestication Linked to Nervous System Genes in Inbred Mouse Strains

Researchers highlighted more than 300 positively selected genes in domesticated mice, including genes linked to nervous system function or behavior in Genome Biology.

ALS Genetic Testing May Be Informative Across Age Ranges, Study Finds

Researchers in the journal Brain identified clinically actionable variants in a significant subset of older ALS patients, prompting them to point to the potential benefits of broader test use.